FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management

Dockets Entered On November 22, 2006
Docket # Title
1978N-0065 Skin Bleaching Drug Products
2004E-0316 Patent Extension for ERTACZO (sertaconazole nitrate), U.S. Patent No. 5,135,943
2006D-0331 Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors; Exception from Informed Consent Requirements for Emergency Research
2006D-0383 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases
2006F-0409 Safe Use of Cetylpyridinium Chloride as an Antimicrobial Agent in a Pre-chiller or Post-chiller Solution for Application to Raw Poultry Carcasses (FAP 6A4767)
2006N-0067 Index of Legally Marketed Unapproved New Animal Drugs for Minor Species
2006N-0352 Comments Relating to the September 6 & 7, 2006 Joint Panel Meeting on Dental Amalgam
2006P-0085 To Exempt the Class II device Cranial Orthoses from Premarket Notification Requirements
2006P-0223 Switch Plan B and equivalent EC drugs from prescription-only to OTC status without age restrictions, exempt from prescription -dispensing requirement any new drug eligible for filing an ANDA
2006P-0394 Revise the labeling requirements for eggs sold in the United States
2006V-0474 Variance for the Poalomar Lux1540 handpiece
1978N-0065 Skin Bleaching Drug Products
EC 89 Dr. ADAM BODIAN Vol #: 14
EC 90 Dr. Kevin Stein Vol #: 14
2004E-0316 Patent Extension for ERTACZO (sertaconazole nitrate), U.S. Patent No. 5,135,943
CEP 1 U.S. Patent and Trademark Office Vol #: 1
2006D-0331 Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors; Exception from Informed Consent Requirements for Emergency Research
EC 59 American College of Emergency Physicians Vol #: 3
EC 60 Division of Medical Ethics, Harvard Medical School Vol #: 3
EC 61 Ms. Nancy King Vol #: 3
2006D-0383 Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases
EC 2024 Mrs. Colleen Domme Vol #: 8
EC 2025 Mrs. Leane VanderPutten Vol #: 8
EC 2026 Mrs. Christine Inglin Vol #: 8
EC 2027 Mr. Ronald Coleman Vol #: 8
EC 2028 Mr. Anthony Adams Vol #: 8
EC 2029 Mrs. Rosemary McNeill Vol #: 8
EC 2030 GLHS Vol #: 8
EC 2031 Mr. Joseph Collison Vol #: 8
EC 2032 Mr. Eric Johnston Vol #: 8
EC 2033 Mr. Gregory and Rebecca Nagel Vol #: 8
EC 2034 Mrs. Karen May Vol #: 8
EC 2035 Mrs. Kristy Kordsmeier Vol #: 8
EC 2036 Mrs. Mary Kustra Vol #: 8
EC 2037 Ms. Mary Quinn Vol #: 8
EC 2038 Miss. Amber Ford Vol #: 8
EC 2039 Mrs. Patricia Crew Vol #: 8
EC 2040 Miss. Cristina Abel Vol #: 8
EC 2041 Mrs. Marie Hoffman, RN Vol #: 8
EC 2042 ACES School Vol #: 8
EC 2043 Mrs. Melissa Shanks Vol #: 8
EC 2044 Mr. Lawrence Flick Vol #: 8
EC 2045 Mrs. Grace Guzowski Vol #: 8
EC 2046 Mrs. Jenny Nelson Vol #: 8
EC 2047 Mr. Philip O'Brien Vol #: 8
EC 2048 Mrs. Anne Gwynn Vol #: 8
EC 2049 Mrs. Janine Gaglio Vol #: 8
EC 2050 Walla Walla Clinic Vol #: 8
EC 2051 Miss. pamela juergens Vol #: 8
EC 2052 Mrs. Anne-Marie Roberts Vol #: 8
EC 2053 Mr. Lawrence Banasky Vol #: 8
EC 2054 lutheran hospital of indiana Vol #: 8
EC 2055 Ms. Mary Ishag Vol #: 8
EC 2056 Dr. Steven Pilkington Vol #: 8
EC 2057 Mrs. LINDA MAURER Vol #: 8
EC 2058 Mrs. Patricia Kinney Vol #: 8
EC 2059 Mrs. Rosemary Jacobs Vol #: 8
EC 2060 Genesis Vol #: 8
EC 2061 Mr. Gary Jacobs Vol #: 8
EC 2062 Mr. Steven Reisiger Vol #: 8
EC 2063 Miss. Margaret Jacobs Vol #: 8
EC 2064 Mr. George Kriegl Vol #: 8
EC 2065 Mrs. Marla Olsen Vol #: 8
EC 2066 Mrs. Mary Clare Peck Vol #: 8
EC 2067 Mr. Terrence Mraz Vol #: 8
EC 2068 Mr. Anthony L. Pometto III Vol #: 8
EC 2069 Mr. Tom Kustner Vol #: 8
EC 2070 Miss. Meghan Mac-Rhyann Vol #: 8
EC 2071 Mr. Anthony Gick Vol #: 8
EC 2072 Mrs. Carol Gick Vol #: 8
EC 2073 Mr. Raymon Carlson Vol #: 8
EC 2074 Mrs. Diane Crist Vol #: 8
EC 2075 Mrs. Joel Jensen Vol #: 8
EC 2076 Mrs. Kathy Martuscelli Vol #: 8
2006F-0409 Safe Use of Cetylpyridinium Chloride as an Antimicrobial Agent in a Pre-chiller or Post-chiller Solution for Application to Raw Poultry Carcasses (FAP 6A4767)
EC 3 Food Vol #: 1
2006N-0067 Index of Legally Marketed Unapproved New Animal Drugs for Minor Species
EC 3 US Fish and Wildlife Service Vol #: 1
2006N-0352 Comments Relating to the September 6 & 7, 2006 Joint Panel Meeting on Dental Amalgam
C 278 Dr. D. Boettcher Vol #: 26
C 279 R. Huffman Vol #: 26
C 280 J. Trustone Vol #: 26
C 281 D. Stockin, MPH Vol #: 26
C 282 J. Presley, PhD Vol #: 26
C 283 J. Thompson Vol #: 26
C 284 D. Veilleux Vol #: 26
C 285 S. Patterson Vol #: 26
C 286 M. Brake Vol #: 26
C 287 D. Barbier Vol #: 26
C 288 B. Scott, RDH Vol #: 26
C 289 Dr. A. Ford Vol #: 26
C 290 J. Ross Vol #: 26
C 291 C. Peeples Vol #: 26
C 292 R. Briggs Vol #: 26
C 293 G and M Pearson Vol #: 26
C 294 P. Kjellstad Vol #: 26
C 295 L. Piatt, MSN, RN, Vol #: 26
C 296 L. Salterberg Vol #: 26
C 297 D Epstein and D. Seborer Vol #: 26
C 298 S. Huff Vol #: 26
C 299 C. Darling Vol #: 26
C 300 W. Harris, M.D. Vol #: 26
C 301 E. Rhodes Vol #: 26
C 302 R. Grupp Vol #: 26
C 303 L. Hays Vol #: 26
C 304 S. Ferris Vol #: 26
C 305 R. Gunnigle Vol #: 26
C 306 C. Oss Vol #: 26
C 307 A. Skillings Vol #: 26
C 308 L. Pruett, RDH Vol #: 26
C 309 A. Chang Vol #: 26
C 310 F. Schubert Vol #: 26
C 311 L. Thomas Vol #: 26
C 312 P. Swint Vol #: 26
C 313 J. Hawthorne Vol #: 26
C 314 Dr. R. McGinn Vol #: 26
C 315 V. Williams Vol #: 26
C 316 E. Brandt Vol #: 26
C 317 V. Williams Vol #: 26
C 318 J. Marcus Vol #: 26
C 319 B. Adler Vol #: 26
C 320 C. HAssett Vol #: 26
C 321 R. Waltman Vol #: 26
C 322 K. Maestas Vol #: 26
C 323 C. Geyer Vol #: 26
C 324 P. Parton Vol #: 26
C 325 D. Green Vol #: 26
C 326 M. Kauderer Vol #: 26
C 327 C. Tuttle Vol #: 26
C 328 K. Burns Vol #: 26
C 329 D. Miller, J.D. Vol #: 26
C 330 P. Moller Vol #: 26
C 331 J. Parfitt Vol #: 26
C 332 S. Mohmand Vol #: 26
C 333 T. Irvin Vol #: 26
C 334 D. Rhoades Vol #: 26
C 335 M. Block Vol #: 26
C 336 S. Rossi Vol #: 26
C 337 R. Fischer, D.D.S. Vol #: 26
C 338 H. Downing Vol #: 26
C 339 B. Sachau Vol #: 26
C 340 M. Cochran Vol #: 26
C 341 Dr. D. Cook, DDS, SC Vol #: 26
C 342 M. Haines Vol #: 26
C 343 N. BAllantyne Vol #: 26
C 344 No siganture Vol #: 26
C 345 A. Thomson Vol #: 26
C 346 S. Michetti Vol #: 26
C 347 S. Simmons Vol #: 26
C 348 J. Brown Vol #: 26
C 349 S. Stratton, DC Vol #: 26
C 350 V. Vazin Vol #: 26
C 351 L. Simon Vol #: 26
C 352 K. Lanford Vol #: 26
C 353 Dr. J. Echols Vol #: 26
C 354 K. Ornstein Vol #: 26
C 355 E. Gioumousis Vol #: 26
C 356 Dr. D. Warner Vol #: 26
C 357 M. Fenci Vol #: 26
C 358 J. Delgado Vol #: 26
C 359 E. Krinsky Vol #: 26
C 360 Dr. N. Meyer Vol #: 26
C 361 L. Hiler Vol #: 26
C 362 B. Dziuban Vol #: 26
C 363 Dr. D. Schmidt Vol #: 26
C 364 D. Liston Vol #: 26
C 365 H. Reinert Vol #: 26
C 366 L. Evanston Vol #: 26
C 367 J. Lewis Vol #: 26
C 368 F. Wasson Vol #: 26
C 369 O. Woodward Vol #: 26
C 370 K. Calabrese Vol #: 26
C 371 M. Jackson, DDS Vol #: 26
C 372 S. Alcantara Vol #: 26
C 373 B. Bills Vol #: 26
C 374 P. Windham Vol #: 26
C 375 A. KArimian, PhD Vol #: 26
C 376 N. Aleem Vol #: 26
C 377 DAMS, Intl Vol #: 26
C 378 DAMS, Intl Vol #: 26
C 379 A. Orlove Vol #: 26
C 380 M. May Vol #: 26
C 381 DAMS, Intl Vol #: 26
C 382 DAMS, Intl Vol #: 26
C 383 J. Alpizar Vol #: 26
C 384 DAMS, Intl Vol #: 26
C 385 P. Gioumousis Vol #: 26
C 386 P. Robertson, BHSc Vol #: 26
C 387 S. Doolittle, DVM Vol #: 26
2006P-0085 To Exempt the Class II device Cranial Orthoses from Premarket Notification Requirements
EC 8 Children's Hospital, Boston Vol #: 2
EC 9 Dr. Joseph Piatt, Jr., MD, FAAP Vol #: 2
EC 10 Dr. Bruce Kaufman, MD Vol #: 2
EC 11 Ms. Sheila Addis Vol #: 2
2006P-0223 Switch Plan B and equivalent EC drugs from prescription-only to OTC status without age restrictions, exempt from prescription -dispensing requirement any new drug eligible for filing an ANDA
EC 714 Mrs. Katherine Huffmire Vol #: 5
2006P-0394 Revise the labeling requirements for eggs sold in the United States
EC 416 Ms. Heather Smith Vol #: 7
2006V-0474 Variance for the Poalomar Lux1540 handpiece
ACK 1 FDA/DDM to Palomar Medical Technologies, Inc. Vol #: 1
VAR 1 Palomar Medical Technologies, Inc. Vol #: 1

Page created on November 24, 2006 kk

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management